NCT02546154View on ClinicalTrials.gov

Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)

CompletedOBSERVATIONAL
Enrollment

359

Participants

Timeline

Start Date

January 22, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Iron Deficiency Anaemia
Interventions
DRUG

10% Iron Isomaltoside 1000

Standard clinical practice and following the Monofer® label (SPC)

Trial Locations (1)

EX2 5DW

Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter

Sponsors

Collaborators (1)

BioStata
All Listed Sponsors
collaborator

BioStata

INDUSTRY

lead

Pharmacosmos UK Ltd

INDUSTRY

NCT02546154 - Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®) | Biotech Hunter | Biotech Hunter